Annual Non Current Assets
N/A
December 1, 2024
Summary
- PFE annual long term assets is not available.
Performance
PFE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Non Current Assets
N/A
December 1, 2024
Summary
- PFE quarterly long term assets is not available.
Performance
PFE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
PFE Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PFE Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Pfizer Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $176.25 B(-1.2%) |
| Jun 2024 | - | $178.37 B(-0.2%) |
| Mar 2024 | - | $178.68 B(-2.5%) |
| Dec 2023 | $43.33 B(-15.5%) | $183.17 B(+29.9%) |
| Sep 2023 | - | $141.01 B(-4.0%) |
| Jun 2023 | - | $146.82 B(+0.9%) |
| Mar 2023 | - | $145.54 B(-0.3%) |
| Dec 2022 | $51.26 B(-14.1%) | $145.94 B(+16.8%) |
| Sep 2022 | - | $124.95 B(-2.3%) |
| Jun 2022 | - | $127.82 B(-1.2%) |
| Mar 2022 | - | $129.42 B(+6.3%) |
| Dec 2021 | $59.69 B(+70.2%) | $121.78 B(+0.4%) |
| Sep 2021 | - | $121.29 B(+0.2%) |
| Jun 2021 | - | $121.11 B(+1.5%) |
| Mar 2021 | - | $119.28 B(+0.1%) |
| Dec 2020 | $35.07 B(+6.9%) | $119.16 B(-9.2%) |
| Sep 2020 | - | $131.25 B(-0.2%) |
| Jun 2020 | - | $131.51 B(-0.1%) |
| Mar 2020 | - | $131.60 B(-2.4%) |
| Dec 2019 | $32.80 B(-34.3%) | $134.79 B(-1.6%) |
| Sep 2019 | - | $136.99 B(+25.5%) |
| Jun 2019 | - | $109.13 B(-0.9%) |
| Mar 2019 | - | $110.13 B(+0.6%) |
| Dec 2018 | $49.93 B(+21.4%) | $109.50 B(-13.3%) |
| Sep 2018 | - | $126.26 B(-1.1%) |
| Jun 2018 | - | $127.68 B(-1.6%) |
| Mar 2018 | - | $129.78 B(-0.7%) |
| Dec 2017 | $41.14 B(+5.6%) | $130.65 B(-0.9%) |
| Sep 2017 | - | $131.86 B(-0.2%) |
| Jun 2017 | - | $132.17 B(-0.5%) |
| Mar 2017 | - | $132.90 B(+0.2%) |
| Dec 2016 | $38.95 B(-11.1%) | $132.67 B(-5.2%) |
| Sep 2016 | - | $139.93 B(+10.3%) |
| Jun 2016 | - | $126.81 B(+4.3%) |
| Mar 2016 | - | $121.63 B(-1.6%) |
| Dec 2015 | $43.80 B(-21.2%) | $123.58 B(-1.8%) |
| Sep 2015 | - | $125.86 B(+15.3%) |
| Jun 2015 | - | $109.16 B(-1.8%) |
| Mar 2015 | - | $111.20 B(-0.7%) |
| Dec 2014 | $55.59 B(-1.2%) | $111.97 B(-2.1%) |
| Sep 2014 | - | $114.38 B(+0.0%) |
| Jun 2014 | - | $114.33 B(+0.3%) |
| Mar 2014 | - | $114.02 B(-1.6%) |
| Dec 2013 | $56.24 B(-13.2%) | $115.86 B(-0.1%) |
| Sep 2013 | - | $116.02 B(-1.6%) |
| Jun 2013 | - | $117.90 B(-3.9%) |
| Mar 2013 | - | $122.64 B(+1.4%) |
| Dec 2012 | $64.83 B(+6.6%) | $120.97 B(-3.6%) |
| Sep 2012 | - | $125.48 B(+1.1%) |
| Jun 2012 | - | $124.08 B(-5.2%) |
| Mar 2012 | - | $130.82 B(+2.9%) |
| Dec 2011 | $60.82 B(+0.6%) | $127.19 B(-4.7%) |
| Sep 2011 | - | $133.40 B(-1.5%) |
| Jun 2011 | - | $135.41 B(-0.9%) |
| Mar 2011 | - | $136.71 B(+1.6%) |
| Dec 2010 | $60.47 B(-1.9%) | $134.55 B(-2.0%) |
| Sep 2010 | - | $137.33 B(-1.9%) |
| Jun 2010 | - | $139.97 B(-3.6%) |
| Mar 2010 | - | $145.20 B(-4.0%) |
| Dec 2009 | $61.67 B(+43.2%) | $151.28 B(+124.1%) |
| Sep 2009 | - | $67.51 B(-0.4%) |
| Jun 2009 | - | $67.79 B(-1.3%) |
| Mar 2009 | - | $68.68 B(+0.9%) |
| Dec 2008 | $43.08 B(-8.1%) | $68.07 B(+1.6%) |
| Sep 2008 | - | $67.02 B(-1.2%) |
| Jun 2008 | - | $67.86 B(+0.5%) |
| Mar 2008 | - | $67.54 B(-1.3%) |
| Dec 2007 | $46.85 B(-1.7%) | $68.42 B(+1.8%) |
| Sep 2007 | - | $67.19 B(-2.3%) |
| Jun 2007 | - | $68.78 B(+0.9%) |
| Mar 2007 | - | $68.15 B(+0.4%) |
| Dec 2006 | $47.66 B | $67.89 B(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $69.86 B(-1.0%) |
| Jun 2006 | - | $70.56 B(-6.6%) |
| Mar 2006 | - | $75.54 B(+7.7%) |
| Dec 2005 | $46.84 B(+19.8%) | $70.14 B(-9.6%) |
| Sep 2005 | - | $77.58 B(-1.5%) |
| Jun 2005 | - | $78.75 B(-2.3%) |
| Mar 2005 | - | $80.58 B(-4.1%) |
| Dec 2004 | $39.09 B(+27.4%) | $83.99 B(+1.0%) |
| Sep 2004 | - | $83.17 B(-0.1%) |
| Jun 2004 | - | $83.28 B(-4.2%) |
| Mar 2004 | - | $86.90 B(+0.9%) |
| Dec 2003 | $30.68 B(+23.8%) | $86.10 B(-1.0%) |
| Sep 2003 | - | $86.99 B(-2.8%) |
| Jun 2003 | - | $89.51 B(+310.1%) |
| Mar 2003 | - | $21.82 B(+1.2%) |
| Dec 2002 | $24.78 B(+29.0%) | $21.57 B(+1.7%) |
| Sep 2002 | - | $21.21 B(+5.1%) |
| Jun 2002 | - | $20.18 B(-0.8%) |
| Mar 2002 | - | $20.35 B(+2.0%) |
| Dec 2001 | $19.21 B(+11.8%) | $19.94 B(+6.0%) |
| Sep 2001 | - | $18.81 B(+8.4%) |
| Jun 2001 | - | $17.34 B(+5.4%) |
| Mar 2001 | - | $16.45 B(+0.8%) |
| Dec 2000 | $17.19 B(+5.4%) | $16.32 B(+0.0%) |
| Sep 2000 | - | $16.32 B(+0.6%) |
| Jun 2000 | - | $16.23 B(+65.7%) |
| Mar 2000 | - | $9.79 B(-35.0%) |
| Dec 1999 | $16.31 B(+64.2%) | $15.06 B(+72.0%) |
| Sep 1999 | - | $8.76 B(+3.1%) |
| Jun 1999 | - | $8.49 B(+2.6%) |
| Mar 1999 | - | $8.28 B(-1.1%) |
| Dec 1998 | $9.93 B(+33.4%) | $8.37 B(+0.8%) |
| Sep 1998 | - | $8.30 B(+0.7%) |
| Jun 1998 | - | $8.25 B(-3.5%) |
| Mar 1998 | - | $8.55 B(+13.2%) |
| Dec 1997 | $7.44 B(+15.1%) | $7.55 B(-6.9%) |
| Sep 1997 | - | $8.11 B(-3.3%) |
| Jun 1997 | - | $8.39 B(+3.2%) |
| Mar 1997 | - | $8.13 B(-0.9%) |
| Dec 1996 | $6.47 B(+5.1%) | $8.20 B(+5.0%) |
| Sep 1996 | - | $7.81 B(+9.6%) |
| Jun 1996 | - | $7.13 B(+5.3%) |
| Mar 1996 | - | $6.77 B(+2.9%) |
| Dec 1995 | $6.15 B(+6.3%) | $6.58 B(-1.6%) |
| Sep 1995 | - | $6.68 B(-4.0%) |
| Jun 1995 | - | $6.96 B(+4.1%) |
| Mar 1995 | - | $6.69 B(+26.0%) |
| Dec 1994 | $5.79 B(+22.3%) | $5.31 B(+6.7%) |
| Sep 1994 | - | $4.98 B(+1.0%) |
| Jun 1994 | - | $4.93 B(+4.9%) |
| Mar 1994 | - | $4.70 B(+2.2%) |
| Dec 1993 | $4.73 B(-12.1%) | $4.60 B(+9.8%) |
| Sep 1993 | - | $4.19 B(-2.0%) |
| Jun 1993 | - | $4.27 B(-0.4%) |
| Mar 1993 | - | $4.29 B(+2.0%) |
| Dec 1992 | $5.38 B(+12.0%) | $4.21 B(-6.4%) |
| Sep 1992 | - | $4.49 B(-1.3%) |
| Jun 1992 | - | $4.55 B(-4.4%) |
| Mar 1992 | - | $4.76 B(-1.4%) |
| Dec 1991 | $4.81 B(+8.4%) | $4.83 B(+3.9%) |
| Sep 1991 | - | $4.64 B(+4.0%) |
| Jun 1991 | - | $4.46 B(-2.0%) |
| Mar 1991 | - | $4.56 B(-1.3%) |
| Dec 1990 | $4.44 B(-1.5%) | $4.62 B(-0.6%) |
| Sep 1990 | - | $4.65 B(+12.3%) |
| Jun 1990 | - | $4.14 B(+5.9%) |
| Mar 1990 | - | $3.91 B(+2.3%) |
| Dec 1989 | $4.50 B(+10.0%) | $3.82 B(+7.8%) |
| Dec 1988 | $4.09 B(-0.1%) | $3.54 B(+25.5%) |
| Dec 1987 | $4.10 B(+75.3%) | $2.82 B(-0.1%) |
| Dec 1986 | $2.34 B(+8.4%) | $2.82 B(+22.5%) |
| Dec 1985 | $2.16 B(-11.5%) | $2.30 B(+43.3%) |
| Dec 1984 | $2.44 B | $1.61 B |
FAQ
- What is the all time high annual non current assets for Pfizer?
- What is the all time high quarterly non current assets for Pfizer?
What is the all time high annual non current assets for Pfizer?
Pfizer all-time high annual long term assets is $183.17 B
What is the all time high quarterly non current assets for Pfizer?
Pfizer all-time high quarterly long term assets is $183.17 B